OBJECTIVE: To provide guidelines for conducting independent assessments in randomized controlled trials (RCTs) of rehabilitation. The article aims to assist those who plan to put independent assessment into practice and to be an introduction for those who are new to independent assessment. ISSUES: Possible causes of unblinding to group allocation are discussed, such as unblinding by other people, the environment, patients and assessors themselves. Other issues discussed in this paper are bias during assessment and monitoring levels of unblinding. CONCLUSION: The importance of monitoring levels of unblinding is stressed. Although it may not be possible to always keep an assessor blind in RCTs of rehabilitation, we should strive for perfection. It is therefore advocated that levels of unblinding should be reported.
OBJECTIVE: To provide guidelines for conducting independent assessments in randomized controlled trials (RCTs) of rehabilitation. The article aims to assist those who plan to put independent assessment into practice and to be an introduction for those who are new to independent assessment. ISSUES: Possible causes of unblinding to group allocation are discussed, such as unblinding by other people, the environment, patients and assessors themselves. Other issues discussed in this paper are bias during assessment and monitoring levels of unblinding. CONCLUSION: The importance of monitoring levels of unblinding is stressed. Although it may not be possible to always keep an assessor blind in RCTs of rehabilitation, we should strive for perfection. It is therefore advocated that levels of unblinding should be reported.
Authors: Maud J L Graff; Myrra J M Vernooij-Dassen; Marjolein Thijssen; Joost Dekker; Willibrord H L Hoefnagels; Marcel G M Olde Rikkert Journal: BMJ Date: 2006-11-17
Authors: E M J Steultjens; J Dekker; L M Bouter; D van Schaardenburg; M A H van Kuyk; C H M van den Ende Journal: Cochrane Database Syst Rev Date: 2004
Authors: C M Wiles; R G Newcombe; K J Fuller; S Shaw; J Furnival-Doran; T P Pickersgill; A Morgan Journal: J Neurol Neurosurg Psychiatry Date: 2001-02 Impact factor: 10.154
Authors: Maud J L Graff; Eddy M M Adang; Myrra J M Vernooij-Dassen; Joost Dekker; L Jönsson; Marjolein Thijssen; Willibrord H L Hoefnagels; Marcel G M Olde Rikkert Journal: BMJ Date: 2008-01-02
Authors: Ailie J Turton; Paul Cunningham; Emma Heron; Frederike van Wijck; Cath Sackley; Chris Rogers; Keith Wheatley; Sue Jowett; Steven L Wolf; Paulette van Vliet Journal: Trials Date: 2013-04-25 Impact factor: 2.279
Authors: Karen L Barker; Christopher J Elliott; Catherine M Sackley; Jeremy C T Fairbank Journal: BMC Musculoskelet Disord Date: 2008-06-28 Impact factor: 2.362
Authors: Heleen Beckerman; Lyan Jm Blikman; Martin Heine; Arjan Malekzadeh; Charlotte E Teunissen; Johannes Bj Bussmann; Gert Kwakkel; Jetty van Meeteren; Vincent de Groot Journal: Trials Date: 2013-08-12 Impact factor: 2.279
Authors: Sarah G Dean; Leon Poltawski; Anne Forster; Rod S Taylor; Anne Spencer; Martin James; Rhoda Allison; Shirley Stevens; Meriel Norris; Anthony I Shepherd; Raff Calitri Journal: BMJ Open Date: 2016-10-03 Impact factor: 2.692
Authors: Gemma M Walker; Sarah Armstrong; Adam L Gordon; John Gladman; Kate Robertson; Marie Ward; Simon Conroy; Gail Arnold; Janet Darby; Nadia Frowd; Wynne Williams; Sue Knowles; Pip A Logan Journal: Clin Rehabil Date: 2015-09-18 Impact factor: 3.477
Authors: Shirley A Thomas; Elizabeth Coates; Roshan das Nair; Nadina B Lincoln; Cindy Cooper; Rebecca Palmer; Stephen J Walters; Nicholas R Latimer; Timothy J England; Laura Mandefield; Timothy Chater; Patrick Callaghan; Avril E R Drummond Journal: Pilot Feasibility Stud Date: 2016-08-10